Byetta Cancer Side Effects May Require Strict Warnings: FDA Officials

Federal drug safety reviewers say that the side effects of Byetta, a diabetes drug, may share thyroid cancer concerns of similar medications, which may result in black-box warning for a new long-acting version of the drug. 

In a report released earlier this month (pdf), FDA officials said animal testing revealing thyroid cancer links with Novo Nordisk’s Victoza, a long-acting diabetes treatment medication, could affect all similar drugs, including Amylin Pharmaceutical’s proposed once-weekly Byetta shot, Bydureon, also known as Byetta LAR. Therefore, strict label warnings may be necessary about the potential Byetta cancer risk to alert users to the possibility of thyroid tumors.

Byetta (exenatide) and Victoza (liraglutide) belong to the same class of drugs, known as GLP-1 analogs. The FDA report expresses concerns that all extended-release diabetes drugs belonging to that family may be linked to thyroid tumors based on tests conducted on rats and monkeys. Victoza was approved in January, but carries the black box warning on potential thyroid cancer. Amylin’s bid for approval of Bydureon was rejected by FDA last month, with the agency requesting more information before it could release the drug on the market.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

In April of last year, when concerns regarding Byetta thyroid cancer side effects came up, Amylin pointed out that Victoza and Byetta are different molecules, and indicated that there was no evidence of any link between Byetta and thyroid cancer. However, a statement from company officials following the FDA report concedes that cancer concerns, while not proven, cannot be ruled out as a side effect of Byetta.

Byetta is a type 2 diabetes drug that is manufactured and distributed jointly by Amylin and Eli Lilly & Co. The drug is used to control blood sugar levels and is part of a class of medications known as incretin mimetics, which imitate natural hormones that lower blood glucose levels.

FDA drug safety reviewers have already expressed concerns that Byetta may be linked to kidney failure and a possible increased risk of pancreatitis. In November, the FDA issued a warning indicating that they have received at least 78 post-marketing reports involving Byetta kidney problems, with 62 of those reports involving users experiencing kidney failure. The alert followed FDA warnings issued in October 2007 and August 2008 of reports involving cases of pancreatitis with Byetta, including severe reports of hemorrhagic pancreatitis and necrotizing pancreatitis, which can be fatal.

Amylin and Eli Lilly also currently face a number of Byetta lawsuits involving allegations that the drug makers failed to adequately warn about the risk of pancreatitis and kidney failure.

4 Comments

  • DeniseAugust 31, 2011 at 11:17 pm

    I too took Byetta from 2009 and in October 2010 was also diagnosed with thyroid cancer for which I had my throid removed followed by radioactive iodine capsule as well. I haven't felt well since, but it obviously was a necessary step.

  • DianneNovember 12, 2010 at 2:58 pm

    I was on Byetta and was diagnosed with thyroid cancer at 56. My thyroid was removed last September and my health has been really comprimised since it was removed. My diabetes has been harder to deal with and physically I have been so exhausted that I could barely function. I have been an emotional fruitcake and told the doctor who removed the thyroid that I which it had never been necessary to [Show More]I was on Byetta and was diagnosed with thyroid cancer at 56. My thyroid was removed last September and my health has been really comprimised since it was removed. My diabetes has been harder to deal with and physically I have been so exhausted that I could barely function. I have been an emotional fruitcake and told the doctor who removed the thyroid that I which it had never been necessary to take it out. No doctor ever told me that Byetta could cause thyroid cancer and I am shocked and angered over this article. Had I been warned, I would never have taken this drug. There were other medications available that could have accomplished the same result. I feel like the lab rat!

  • NancyOctober 26, 2010 at 1:02 am

    I was on byetta & yes I lost weight but I also got thyroid cancer. I had to have my complete thyroid removed. I was 55 years old and no family history of thyroid cancer whatsoever. I did see a warning in that byetta could cause a thyroid tumor in the mice, but nothing proven in humans. I would really like to know if anyone else has had this same situation. Thanks

  • OmamahOctober 21, 2010 at 3:38 am

    My Doctor started me on Beytta since January 2010 for weight loss reasons, I am not a diabetic, but it seems working well along with the Metformin Hydrocloride since I lost so much weight so far. But what is worrying me, is that Thyroid nodules are now discovered in my gland, it das FNAed twice with favoring benign nodules, But still micro follicles were seen, and I have an enlarged lymph node, 4c[Show More]My Doctor started me on Beytta since January 2010 for weight loss reasons, I am not a diabetic, but it seems working well along with the Metformin Hydrocloride since I lost so much weight so far. But what is worrying me, is that Thyroid nodules are now discovered in my gland, it das FNAed twice with favoring benign nodules, But still micro follicles were seen, and I have an enlarged lymph node, 4cm, that is going to be biopsied next week!!

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted 2 days ago)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 4 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.